Clarithromycin Tablet, Film Coated, Extended Release
Product Images NDC 73473-911

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 73473-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solaris Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Claripr-container-label-500mg (Claripr Container Label 500mg)

This text provides information on a film-coated tablet containing 500 mg of clarithromycin. It specifies the National Drug Code (NDC) as 73473-911-60. The storage conditions are recommended to be at 20° to 25°C (68° to 77°F). The tablets are mentioned to be Extended-Release. The manufacturer is indicated as Solas Pharma Corporation, with an address in Somerset, NJ, USA. There is also a reference to full prescribing information and a caution to not accept if the seal over the bottle is broken.*

FDA Label Image

Chemical Structure For Clarithromycin (Clarithromycin Tab Stucture)

FDA Label Image

Steady State Graph (Clarithromycin Tabs Steady Graph)

This information shows the Mean Plasma Concentration (in mcg/mL) of Clarithromycin extended-release (2 x 500 mg q24h) and Clarithromycin (500 mg q12h) over time after dosing (in hours). This data can be useful for evaluating the pharmacokinetics and dosing schedule of these medications.*

FDA Label Image

Logo01 (Logo01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.